Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth Solutions to Sickle Cell Disease Patients Nov 11, 2021 8:23am EST
Emmaus Life Sciences Enters into Agreement with Asembia to Provide Expanded Patient Support Services Nov 04, 2021 8:23am EDT
Emmaus Life Sciences Submits Application for U.A.E. Marketing Authorization for Endari® Oct 26, 2021 8:23am EDT
Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine Oct 12, 2021 8:23am EDT
Emmaus Life Sciences Reports Financial Results for the Six Months Ended June 30, 2021 Sep 02, 2021 8:45am EDT
Emmaus Life Sciences Announces Submission of Endari® Marketing Authorization Application in Kuwait Jul 15, 2021 9:00am EDT
